Adalimumab-induced cutaneous lupus [13]

Clinical and Experimental Dermatology

Volumn 32, Issue 5, 2007, Pages 593-594

  Sheth, N ^a   Greenblatt, D ^a   Patel, S ^a   Acland, K ^a  

^a EALING HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; HYDROXYCHLOROQUINE; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; CASE REPORT; DISEASE CONTROL; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LABORATORY TEST; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MIDDLE AGED;

EID: 34547734429     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02503.x     Document Type: Letter

References (5)

1. Bleumink GS, ter Borg EJ, Ramselaar CG et al. Etanercept-induced subacute cutaneous lupus erythematosus. Rheumatology 2001 40 : 1317 19.
2. Stratigos AJ, Antoniou C, Stamathioudaki S et al. Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol 2004 29 : 150 3.
3. Cairns AP, Duncan MK, Hinder AE et al. New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis. Ann Rheum Dis 2002 61 : 1031 2.
4. van Rijthoven AW, Bijlsma JW. Canninga-van Dijk M et al. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level. Rheumatology 2006 45 : 1317 19.
5. Pisetsky DS. Tumour necrosis factor alpha blockers and the induction of anti-DNA autoantibodies. Arthritis Rheum 2000 43 : 2383 90.